| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000162206 |
| P356 | DOI | 10.1186/1471-2407-10-455 |
| P932 | PMC publication ID | 2940799 |
| P698 | PubMed publication ID | 20735817 |
| P5875 | ResearchGate publication ID | 45827179 |
| P50 | author | Lodewyk F A Wessels | Q89966632 |
| Christiaan Klijn | Q41050637 | ||
| Arno Velds | Q54026511 | ||
| Henne Holstege | Q61281193 | ||
| Jos Jonkers | Q88723772 | ||
| P2093 | author name string | Petra M Nederlof | |
| Xiaoling Liu | |||
| Simon A Joosse | |||
| Ron Kerkhoven | |||
| Sjoerd Klarenbeek | |||
| Erik van Beers | |||
| Eva Schut | |||
| P2860 | cites work | Initial sequencing and comparative analysis of the mouse genome | Q22122521 |
| Activating Smoothened mutations in sporadic basal-cell carcinoma | Q24318403 | ||
| Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
| A census of human cancer genes | Q24647081 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer | Q28143255 | ||
| Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 | Q28212276 | ||
| Cross-species oncogenomics in cancer gene identification | Q28249773 | ||
| Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure | Q28512661 | ||
| Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
| Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database | Q29616468 | ||
| Hallmarks of 'BRCAness' in sporadic cancers | Q29618825 | ||
| Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. | Q30714274 | ||
| Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data | Q31142505 | ||
| A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization | Q33196501 | ||
| Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population | Q33933643 | ||
| BRCA1 and BRCA2--breast cancer susceptibility genes | Q34044064 | ||
| The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology? | Q34184029 | ||
| Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma. | Q34398691 | ||
| Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer | Q35901185 | ||
| Etiology of hormone receptor-defined breast cancer: a systematic review of the literature | Q35910121 | ||
| BRCA1 regulates human mammary stem/progenitor cell fate | Q36446479 | ||
| Structure meets function--centrosomes, genome maintenance and the DNA damage response | Q36541054 | ||
| Special considerations in mouse models of breast cancer. | Q37023676 | ||
| Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers | Q37272977 | ||
| Atlas of Genetics and Cytogenetics in Oncology and Haematology, year 2003. | Q39790710 | ||
| Aurora-A amplification associated with BRCA2 mutation in breast tumours | Q40252484 | ||
| Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer | Q42450903 | ||
| BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays | Q42506232 | ||
| Integrated profiling of basal and luminal breast cancers. | Q42522755 | ||
| The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. | Q43974233 | ||
| Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors. | Q44590619 | ||
| Rosetta error model for gene expression analysis | Q48454987 | ||
| Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer | Q52544495 | ||
| Microarray comparative genomic hybridization profile of a murine model for epithelial ovarian cancer reveals genomic imbalances resembling human ovarian carcinomas | Q53355281 | ||
| Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. | Q53464409 | ||
| Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome | Q57266956 | ||
| Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene | Q57274900 | ||
| Rearrangements involving the 13q chromosome arm committed to the progression of laryngeal squamous cell carcinoma | Q58316578 | ||
| Comparative Genomic Hybridization | Q59359148 | ||
| Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors | Q78598262 | ||
| Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH | Q81786551 | ||
| Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH | Q84544507 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 455 | |
| P577 | publication date | 2010-08-24 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers | |
| P478 | volume | 10 |
| Q30497664 | BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations |
| Q37137914 | BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1 |
| Q61124716 | Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer |
| Q34485060 | Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution |
| Q51252315 | DNA Damage Follows Repair Factor Depletion and Portends Genome Variation in Cancer Cells after Pore Migration |
| Q39454483 | Dysfunctional telomeres in human BRCA2 mutated breast tumors and cell lines |
| Q34515894 | Frequent alteration of the tumor suppressor gene APC in sporadic canine colorectal tumors |
| Q38798405 | Genetic Dissection of Cancer Development, Therapy Response, and Resistance in Mouse Models of Breast Cancer |
| Q37933098 | Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers |
| Q33827045 | Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy |
| Q47285585 | Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple Negative Breast Cancer |
| Q27308072 | Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2 |
| Q33744507 | KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data. |
| Q33988970 | Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases |
| Q58776633 | Mouse models in the era of large human tumour sequencing studies |
| Q37369422 | Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma |
| Q90708456 | Nuclear Mechanics and Cancer Cell Migration |
| Q38578970 | Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development |
| Q37844487 | Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer |
Search more.